Key result
Higher body fat correlates with adverse lipids in PCOS, with phenotype-specific HDL and triglyceride effects.
Why the study?
PCOS is linked to metabolic disturbances and cardiovascular risk, but the impact of percentage body fat on lipid profiles across distinct Rotterdam phenotypes remains unclear.
Does the relationship between percentage body fat and lipid profile vary across PCOS phenotypes defined by the Rotterdam criteria?
Cross-Sectional (n=343)
Does the relationship between percentage body fat and lipid profile vary across PCOS phenotypes defined by the Rotterdam criteria?
The association between percentage body fat and adverse lipid profiles varies by PCOS phenotype, suggesting a need for individualized metabolic risk management.
Answers are grounded in this paper and cite their sources.
PBF-lipid associations may vary by PCOS phenotype; hypothesis-generating and requires prospective validation before clinical application.
OBJECTIVES: Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder linked to metabolic disturbances and increased cardiovascular risk. While the Rotterdam criteria classify PCOS into distinct phenotypes, the impact of percentage body fat (PBF) on lipid profiles across these subtypes remains unclear. This study aims to assess whether the association between PBF and lipid parameters differs among PCOS phenotypes. The research question is: "Does the relationship between PBF and lipid profile vary across PCOS phenotypes defined by the Rotterdam criteria?". MATERIAL AND METHODS: A cross-sectional analysis was conducted on 343 PCOS patients, categorized into four phenotypes using the Rotterdam criteria. Body composition was assessed using bioelectrical impedance analysis (InBody 170). Clinical and laboratory data were analyzed to explore phenotype-specific metabolic differences. RESULTS: Results show that higher PBF correlates with adverse lipid profiles, including elevated triglycerides (TG) and low-density lipoproteins (LDL) levels and decreased high-density lipoproteins (HDL) levels. Phenotype A exhibited the strongest inverse relationship between PBF and HDL, while Phenotype D showed the most pronounced positive correlation between PBF and triglycerides. These findings highlight the heterogeneity in metabolic risk among Rotterdam phenotypes of PCOS patients. CONCLUSIONS: There is phenotype-specific association between PBF and lipid components in PCOS. Phenotype A is particularly vulnerable to HDL reduction, while phenotype D shows the strongest triglyceride elevation. This study underscores the importance of individualized management strategies targeting body fat reduction to improve lipid profiles and reduce cardiovascular risk in PCOS patients. Specific interventions tailored based on phenotype and body composition may optimize treatment outcomes.
No takes yet. Share an insight, caveat, or question.
Pluta et al. (2026) conducted a cross-sectional in Polycystic ovary syndrome (PCOS) (n=343). Percentage body fat (PBF) was evaluated on Lipid profiles (triglycerides, LDL, HDL). Higher percentage body fat correlated with adverse lipid profiles in PCOS, with Phenotype A showing the strongest HDL reduction and Phenotype D the strongest triglyceride elevation.
Synapse has enriched 10 related papers. Consider them for comparative context: